Editas Medicine (EDIT) 10-K2024 FY Annual report

Filed: 5 Mar 25, 4:21pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. senior Avg

New words: allelic, antitrust, APA, arguing, Article, authorisation, biodistribution, biomarker, Cas, Cellestic, Cellistic, CEO, Chevron, CMC, CMO, CODM, complaint, concrete, conjugated, contrary, Corner, DAP, deepening, deletion, Disaggregation, DMC, downstream, DRI, eighteen, Eligo, enjoyably, Ensoma, Exit, extrahepatic, figure, filer, flat, float, FTC, fulfilled, gave, GFP, HSPC, Idaho, imbalance, impending, indel, intervene, Invasion, IRP, Jarkesy, knockdown, LNP, longstanding, Loper, LP, mastery, missing, Missouri, moiety, MRDC, nanoparticle, nChroma, negligible, notably, OCR, opted, Organisation, Orna, outright, overturned, Pfizer, plug, Postemployment, presidential, presumptive, Profluent, progenitor, progeny, prosecutorial, protracted, Raimondo, ratably, ratio, reconciled, relabel, reproductive, reprogrammable, rheumatoid, roadmap, RR, RRs, Sanofi, seasoned, serum, shelf, silent, simpler, skepticism, speak, speed, stripped, Subtopic, subtracting, successor, summer, TD, text, theoretical, thrive, tLNP, top, toxicology, trait, Treaty, unanimously, unavoidable, unfair, unforeseeable, unissued, unpermitted, upregulate, upregulation, upstream, USA, Video, Welfare, wiretapping, won, worsen, Yoltech

Removed: accepting, accessible, affordability, allogenic, amortize, attribute, back, background, billed, bone, border, BRILLIANCE, Chroma, coding, collateralized, combat, complexed, congenital, construct, convey, COSO, deformability, deposit, differentiate, directing, dispose, disposition, DSMB, durability, EPO, equitable, Ernst, estimation, excessive, explore, favored, foundation, gouging, immaterial, inevitable, invoicing, leber, LLP, main, marrow, multipotent, nationwide, onset, oxygen, pancellular, perpetual, pertain, progressing, proportion, qualitatively, quantitively, reconsider, recurrent, regime, rescind, rescinded, seventeen, showed, subjected, sustained, tie, tolerability, train, undermine, unedited, unmarketable, unqualified, waive, Young

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

EDIT similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with this Annual Report on Form 10-K of Editas Medicine, Inc. (the “Company”) for the year ended December 31, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned officers of the Company hereby certifies, pursuant to 18 U.S.C. (section) 1350, as adopted pursuant to (section) 906 of the Sarbanes-Oxley Act of 2002, that to the best of her or his knowledge:

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Dated: March 5, 2025

By:			/s/ Gilmore O’Neill
			Gilmore O’Neill
			President and Chief Executive Officer


By:			/s/ Erick Lucera
			Erick Lucera
			Chief Financial Officer